triamcinolone has been researched along with fluocinonide in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Jurs, PC; Stouch, TR | 1 |
| Bodor, N; Harget, AJ; Phillips, EW | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Kaidbey, KH; Kligman, AM | 1 |
| Shellow, WV | 1 |
| Chalker, DK; Smith, JG; Wehr, RF | 1 |
| Cornell, RC | 1 |
| Engel, MF | 1 |
| Collins, JP; Mailhot, R; Perras, MA; Raymond, GP; Ricard, P; Wilkinson, RD | 1 |
| Castellano, LM; Fenske, NA; Shenefelt, PD | 1 |
| Iida, T; Muramatsu, T; Shirai, T | 1 |
| Buser, D; Magnin, P; Meier, E; Rees, TD | 1 |
| Agbaba, D; Vladimirov, S; Zivanov-Stakić, D; Zubac, K | 1 |
| Egges, M; Roodenburg, JL; van der Hem, PS; van der Wal, JE | 1 |
| Meier, MJ; Tam, CC | 1 |
| Alniemi, DT; Bridges, AG; Camilleri, MJ; Davis, MD; El-Azhary, RA; McEvoy, MT; Wetter, DA | 1 |
| Aung, PP; Curry, JL; Duke, TC; Glitza Oliva, IC; Ledesma, DA; Marques-Piubelli, ML; Nagarajan, P; Nelson, KC; Prieto, VG; Tetzlaff, MT; Torres-Cabala, CA; Wistuba, II | 1 |
| Al-Hadlaq, M; Bajonaid, A; Chirravur, P; Hussein, M; Intini, R; Klein, BA; Sandhu, S; Sonis, S; Sroussi, H; Treister, N; Vacharotayangul, P; Xu, Y | 1 |
1 review(s) available for triamcinolone and fluocinonide
| Article | Year |
|---|---|
Oral lichen planus: comparative efficacy and treatment costs-a systematic review.
Topics: Administration, Topical; Calcineurin Inhibitors; Clobetasol; Cyclosporins; Dexamethasone; Fluocinonide; Health Care Costs; Humans; Lichen Planus, Oral; Steroids; Tacrolimus; Treatment Outcome; Triamcinolone | 2022 |
4 trial(s) available for triamcinolone and fluocinonide
| Article | Year |
|---|---|
Use of a polyester fiber sponge as an adjunct in the treatment of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Coal Tar; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Keratins; Male; Middle Aged; Ointments; Polyesters; Psoriasis; Triamcinolone | 1978 |
Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.
Topics: Double-Blind Method; Drug Administration Schedule; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Middle Aged; Ointments; Psoriasis; Triamcinolone | 1983 |
Treatment of psoriasis with amcinonide 0.1 percent and fluocinonide 0.05 percent ointments. A comparative double-blind study.
Topics: Administration, Topical; Clinical Trials as Topic; Double-Blind Method; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Psoriasis; Random Allocation; Triamcinolone | 1982 |
Therapy of infected dermatitis: comparative response to two corticosteroid antimicrobial creams.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Eczema; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Infant; Male; Middle Aged; Ointments; Skin Diseases, Infectious; Triamcinolone | 1980 |
13 other study(ies) available for triamcinolone and fluocinonide
| Article | Year |
|---|---|
Computer-aided studies of the structure-activity relationships between the structure of some steroids and their antiinflammatory activity.
Topics: Anti-Inflammatory Agents; Humans; Numerical Analysis, Computer-Assisted; Steroids; Structure-Activity Relationship; Vasoconstriction | 1986 |
Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach.
Topics: Animals; Anti-Inflammatory Agents; Drug Synergism; Granuloma; Humans; Models, Chemical; Rats; Steroids; Structure-Activity Relationship; Vasoconstriction | 1983 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Assay of topical corticosteroids. Efficacy of suppression of experimental Rhus dermatitis in humans.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone Valerate; Dermatitis, Toxicodendron; Dexamethasone; Drug Administration Schedule; Fluocinolone Acetonide; Fluocinonide; Glucocorticoids; Humans; Hydrocortisone; Models, Biological; Ointments; Triamcinolone | 1976 |
Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Atrophy; Betamethasone; Body Weight; Dexamethasone; Disease Models, Animal; Flumethasone; Fluocinolone Acetonide; Fluocinonide; Flurandrenolone; Hydrocortisone; Male; Rats; Skin Diseases; Telangiectasis; Triamcinolone | 1976 |
Successful treatment of albopapuloid epidermolysis bullosa (Pasini's variant) with pulse topical corticosteroid therapy.
Topics: Administration, Cutaneous; Adult; Albinism; Clobetasol; Epidermolysis Bullosa Dystrophica; Fluocinonide; Humans; Male; Ointments; Skin Diseases, Papulosquamous; Treatment Outcome; Triamcinolone | 1993 |
Pemphigoid and pemphigus foliaceus successfully treated with topical corticosteroids.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Clobetasol; Dexamethasone; Female; Fluocinonide; Glucocorticoids; Humans; Leg Dermatoses; Male; Middle Aged; Ointments; Pemphigoid, Bullous; Pemphigus; Triamcinolone | 1996 |
[Oral lichen planus. 2. Therapy possibilities and current treatment concepts].
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Inflammatory Agents; Cyclosporins; Female; Fluocinonide; Follow-Up Studies; Gels; Glucocorticoids; Humans; Lichen Planus, Oral; Male; Middle Aged; Oral Hygiene; Prednisone; Retinoids; Time Factors; Triamcinolone | 2001 |
Determination of triamcinolone, triamcinolone acetonide and fluocinonide in dosage forms.
Topics: Anti-Inflammatory Agents; Calibration; Chromatography, Thin Layer; Fluocinonide; Indicators and Reagents; Isoniazid; Ointments; Reference Standards; Spectrophotometry, Ultraviolet; Tablets; Triamcinolone; Triamcinolone Acetonide | 1990 |
CO2 laser evaporation of oral lichen planus.
Topics: Adult; Female; Fluocinonide; Follow-Up Studies; Glucocorticoids; Humans; Laser Therapy; Lasers, Gas; Lichen Planus, Oral; Male; Middle Aged; Mouth Mucosa; Pain; Recurrence; Retreatment; Retrospective Studies; Tongue Diseases; Triamcinolone | 2008 |
Discrete papular lichen myxedematosus with an unusual segmental presentation.
Topics: Diagnosis, Differential; Drug Therapy, Combination; Fluocinonide; Glucocorticoids; Humans; Male; Scleromyxedema; Triamcinolone; Young Adult | 2014 |
Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996-2013.
Topics: Acute Generalized Exanthematous Pustulosis; Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clindamycin; Dermatitis; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Hydrocortisone; Male; Middle Aged; Mucous Membrane; Prednisone; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Triamcinolone; Young Adult | 2017 |
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
Topics: Acitretin; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dermatitis; Drug Eruptions; Drug Therapy, Combination; Exportin 1 Protein; Female; Fluocinonide; Glucocorticoids; Humans; Hypertrophy; Immune Checkpoint Inhibitors; Karyopherins; Keratolytic Agents; Lichenoid Eruptions; Melanoma; Programmed Cell Death 1 Receptor; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Triamcinolone | 2020 |